Using 5′-PTMs to repair mutant β-globin transcripts
- 7 June 2007
- journal article
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 13 (8) , 1317-1327
- https://doi.org/10.1261/rna.525607
Abstract
Trans-splicing has been used to repair mutant RNA transcripts via competition for the spliceosome using pre-trans-splicing molecules, or “PTMs.” Previous studies have demonstrated that functional PTMs can be designed for either 3′- or 5′-exon replacement, with a vast majority of the work to date focusing on repair of mutations within internal exons and via 3′-exon replacement. Here, we describe the first use oftrans-splicing to target the first exon and intron of a therapeutically relevant gene and repair the mutant RNA by 5′-exon replacement. Our results show that 5′-PTMs can be designed to repair mutations in the β-globin transcript involved in sickle cell anemia and β-thalassemia while providing insight into considerations for competition betweentrans- versuscis-splicing in mammalian cells. Target transcripts with impairedcis-splicing capabilities, like those produced in some forms of β-thalassemia, are more efficiently repaired viatrans-splicing than targets in whichcis-splicing is unaffected as with sickle β-globin. This study reveals desirable characteristics in substrate RNAs fortrans-splicing therapeutics as well as provides an opportunity for further exploration into general splicing mechanisms via 5′-PTMs.Keywords
This publication has 41 references indexed in Scilit:
- Spliceosome-Mediated RNATrans-Splicing with Recombinant Adeno-Associated Virus Partially Restores Cystic Fibrosis Transmembrane Conductance Regulator Function to Polarized Human Cystic Fibrosis Airway Epithelial CellsHuman Gene Therapy, 2005
- Spectrum of β-Globin Gene Mutations Among Thalassemia Patients in the West Bank Region of PalestineHemoglobin, 2005
- Impact of β globin gene mutations on the clinical phenotype of β thalassemia in IndiaBlood Cells, Molecules, and Diseases, 2004
- A Recombinant Human Hemoglobin with Anti-sickling Properties Greater than Fetal HemoglobinJournal of Biological Chemistry, 2004
- Development of spliceosome‐mediated RNA trans‐splicing (SMaRT™) for the correction of inherited skin diseasesExperimental Dermatology, 2003
- In Vivo Kinetics of mRNA Splicing and Transport in Mammalian CellsMolecular and Cellular Biology, 2002
- Messenger RNA Repair and Restoration of Protein Function by Spliceosome-Mediated RNA Trans-SplicingMolecular Therapy, 2001
- Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicingGene Therapy, 2000
- A trans-splicing model for the expression of the tripartite nad5 gene in wheat and maize mitochondria.Plant Cell, 1991
- Abnormal human haemoglobins. III the chemical difference between normal and sickle cell haemoglobinsBiochimica et Biophysica Acta, 1959